A human CD4 monoclonal antibody for the treatment of T cell lymphoma combines inhibition of T cell signaling by a dual mechanism with potent Fc-dependent effector activity

Translated title of the contribution: A human CD4 monoclonal antibody for the treatment of T cell lymphoma combines inhibition of T cell signaling by a dual mechanism with potent Fc-dependent effector activity

D.A. Rider, C.E.G. Havenith, R. de Ridder, J. Schuurman, C. Favre, J.C. Cooper, S.M. Walker, O. Baadsgaard, S. Marschner, J.G.J. van de Winkel, J. Cambier, P.W.H.I. Parren, D.R. Alexander

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionA human CD4 monoclonal antibody for the treatment of T cell lymphoma combines inhibition of T cell signaling by a dual mechanism with potent Fc-dependent effector activity
Original languageUndefined/Unknown
Pages (from-to)9945-9953
Number of pages9
JournalCancer Research
Volume67
Publication statusPublished - 2007

Cite this